A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

How I treat patients with thrombotic thrombocytopenic purpura: 2010

(2010) J. N. George   BLOOD

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

(2010) V. MCDONALD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Survival and relapse in patients with thrombotic thrombocytopenic purpura

(2009) J. A. K. Hovinga et al.   BLOOD

Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura

(2009) Spero R. Cataland et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link

(2009) M. SCULLY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse

(2009) Huichun Zhan et al.   TRANSFUSION

Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features

(2008) Marie Scully et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab as an adjunct to plasma exchange in TTP: A report of 12 cases and review of literature

(2008) Sushama Jasti et al.   JOURNAL OF CLINICAL APHERESIS